News

Amerise Bioscienes Limited, formerly known as Amradeep Industries Limited, will close its trading window for securities dealings from October 1, 2026, until 48 hours after the announcement of its unaudited financial results for the second quarter ended September 30, 2026, in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

Amerise Bioscienes Limited, formerly known as Amradeep Industries Limited, will close its Register of Members and Share Transfer Books from September 17, 2026, to September 24, 2026, for its Annual General Meeting scheduled on September 24, 2026, according to a regulatory filing with the BSE Limited. E-voting will commence on September 21, 2026, at 09:00 A.M. and conclude on September 23, 2026, at 05:00 P.M., with a cut-off date for voting eligibility of September 17, 2026.

Net Loss of Amerise Biosciences reported to Rs 0.08 crore in the quarter ended June 2026 as against net loss of Rs 0.01 crore during the previous quarter ended June 2025. There were no Sales reported in the quarter ended June 2026 and during the previous quarter ended June 2025.Powered by Capital Market - Live News

Amerise Biosciences will hold a meeting of the Board of Directors of the Company on 3 August 2026.

Net profit of Amerise Biosciences declined 45.45% to Rs 0.06 crore in the quarter ended March 2026 as against Rs 0.11 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.For the full year,net profit rose 100.00% to Rs 0.02 crore in the year ended March 2026 as against Rs 0.01 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.Powered by Capital Market - Live News